Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis.

Caroline Michèle AndristLukas JoergThomas GreuterAnna GschwendAlex StraumannArthur Helbling

Published in: BMC gastroenterology (2020)

Orodispersible budesonide is increasingly prescribed for the treatment of eosinophilic esophagitis. The development of oropharyngeal symptoms after initiating should alert the treating physician to the possibility of a hypersensitivity reaction.

Keyphrases

drug induced
primary care
emergency department
chronic rhinosinusitis
sleep quality